menu
    • menu

    Company profile for CytomX Therapeutics

    NEW Drugs in Dev: 11
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Fostering a culture grounded in our vision, mission and values, CytomX is an Xtraordinary clinical-stage biopharmaceutical company with a unique approach to treating cancer and a team dedicated to make a difference. We call this the CytomX Factor. Cytomx has four ProbodyTM programs in the clinic, our goal is to reinvent therapeutic antibodies for the treatment of cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CytomX TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    151 Oyster Point Blvd, Suite 400 South San Francisco, CA
    Telephone
    Telephone
    94080-1913
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cytomx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cytomx-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cytomxinc?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CytomX Leases Floor at Wareham Development's EmeryStation Campus
    CytomX Leases Floor at Wareham Development's EmeryStation Campus

    21 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260121734483/en/Wareham-Development-Leases-Full-Floor-at-EmeryStation-Research-Campus-to-CytomX-Therapeutics

    BUSINESSWIRE
    21 Jan 2026
    Share Share
    Cytomx Therapeutics Unveils 2026 Business Update And Milestones
    Cytomx Therapeutics Unveils 2026 Business Update And Milestones

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215318/37704/en/CytomX-Therapeutics-Announces-Business-Update-and-Company-Milestones-for-2026.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Cytomx Therapeutics To Present At December Investor Conferences
    Cytomx Therapeutics To Present At December Investor Conferences

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194263/37704/en/CytomX-Therapeutics-to-Present-at-Upcoming-December-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Cytomx Therapeutics To Present At Jefferies London Health Conf
    Cytomx Therapeutics To Present At Jefferies London Health Conf

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187239/37704/en/CytomX-Therapeutics-to-Present-at-the-Jefferies-London-Healthcare-Conference.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Cytomx Therapeutics Reveals Q3 2025 Financials & Business
    Cytomx Therapeutics Reveals Q3 2025 Financials & Business

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183162/37704/en/CytomX-Therapeutics-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Cytomx To Unveil CX-801 Phase 1 Biomarker Data At SITC Meeting
    Cytomx To Unveil CX-801 Phase 1 Biomarker Data At SITC Meeting

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180466/37704/en/CytomX-Therapeutics-to-Present-CX-801-Phase-1-Monotherapy-Biomarker-Data-at-the-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search